|
⚲
|
| Keyboard |
| Christopher Schreiber | |
|---|---|
| Firm | |
| Address | 1185 Avenue of The Americas Suite 249 New York, NY 10036 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| TNF Pharmaceuticals Inc | 021-556846 | Director | 7.0 M of 7.0 M |
||
| MYMD Pharmaceuticals Inc | 021-514758 | Director | 15.2 M of 15.2 M |
||
| MYMD Pharmaceuticals Inc | 021-514757 | Director | 26.9 M of 26.9 M |
||
| MYMD Pharmaceuticals Inc | 021-457338 | Director | of 7.4 M |
||
| Akers Biosciences Inc | 021-381437 | Executive Officer | 18.1 M of 18.1 M |
||
| Akers Biosciences Inc | 021-372987 | Executive Officer | |||
| Akers Biosciences Inc | 021-367476 | Executive Officer | 0.5 M of 0.5 M |
||
| Akers Biosciences Inc | 021-364932 | Executive Officer | 0.5 M of 0.5 M |
||
| Akers Biosciences Inc | 021-364494 | Executive Officer | 1.2 M of 2.7 M |
||